Zdrowie i gospodarka · 15/08/1994
FDA Approves Phoenix Pharmaceutical's Ketamine Hydrochloride Injection for Animal Use
The US Food and Drug Administration has approved an abbreviated new animal drug application filed by Phoenix Pharmaceutical, Inc. for ketamine hydrochloride injection in cats and subhuman primates for restraint and minor surgical procedures.
Source: Federal Register — Health and Human ServicesOpen original release →